Investment
Features
FeesSafety
Academy
More
Pluang+

Synthetic contracts price SpaceX IPO at $2.4T, sparking debate on its massive valuation ahead of 2026 listing.

Market News
21 May 2026
24/7 Wall Street
View Source
Bullish
pluang ai news

A synthetic futures contract on Hyperliquid implies a SpaceX valuation of about $2.4 trillion, far above its reported IPO target of $1.75 to $2 trillion. This price reflects speculative bets rather than actual share value, highlighting strong but uncertain demand ahead of a potential June 2026 IPO. Analysts project SpaceX revenue growing to $22-24 billion by 2026, mainly from satellite internet, but concerns remain over market volatility and pricing accuracy due to the contract’s leveraged nature. The real IPO price will ultimately depend on the official prospectus and actual investor demand, with significant market impact expected on listing day.

More News

Investors in Putnam mutual funds may claim losses in a new class action lawsuit.

Investors in Putnam mutual funds may claim losses in a new class action lawsuit.

The Rosen Law Firm is investigating potential securities claims against Putnam Investment Management, LLC, alleging that the company may have provided misleading business information to investors. Investors who purchased Putnam stock-based mutual fun...

Market News
Bearish
1 hour ago
Stocks fall sharply due to legal probes, financing plans, and volatile listings today.

Stocks fall sharply due to legal probes, financing plans, and volatile listings today.

Several stocks experienced significant declines today driven by company-specific events. SANUWAVE Health's shares dropped 39.21% despite strong revenue guidance, Twin Vee Powercats fell 30.95% amid a legal investigation, and Gorilla Technology declin...

Market News
Bearish
2 hours ago
Study finds 2 years of lenalidomide maintenance as effective as indefinite treatment for multiple myeloma.

Study finds 2 years of lenalidomide maintenance as effective as indefinite treatment for multiple myeloma.

The phase III ENDURANCE trial showed that two years of lenalidomide maintenance therapy offers the same long-term survival benefit as indefinite treatment for patients with standard-risk multiple myeloma who are not transplant candidates. After nearl...

Company Fundamentals
Neutral
2 hours ago
Stock market jumps on strong corporate news and high trading volumes in EV and green energy sectors

Stock market jumps on strong corporate news and high trading volumes in EV and green energy sectors

The stock market saw significant gains driven by corporate announcements and high trading volumes, particularly in battery technology, electric vehicles, and green energy sectors. Electrovaya surged 49.05% after announcing a commercial deal with Amaz...

Market News
Bullish
2 hours ago
Akamai officer sells shares amid shift to cloud and cybersecurity growth

Akamai officer sells shares amid shift to cloud and cybersecurity growth

An Akamai Technologies executive sold 3,100 shares as the company shifts focus from its declining content delivery network business to high-growth cloud infrastructure and cybersecurity services. This strategic pivot is supported by a $1.8 billion, s...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App